On a Wednesday in late May, Rotem Rosen filed a notice with the Tel Aviv Stock Exchange. His firm, MRR Development, had secured $135 million from Israeli institutional investors. The rate: 6.2 percent. The collateral: a Hotel Indigo on Manhattan's Lower East Side and a development site in Miami's Arts & Entertainment District.
Rosen is no stranger to Israeli capital. He and his partner, Indian billionaire Anand Mahindra, acquired the 171 Ludlow Street hotel—home to rooftop bar Mr. Purple—in 2018. They also control a 1.9 million-square-foot mixed-use development site in Miami, anchored by a Price Choice supermarket and a preschool. The site closed in 2022 after a four-year contract period.
The $135 million raise refinances a prior $113 million Israeli bond issuance from 2022. That earlier deal carried a 4.5 percent coupon. The new paper costs 170 basis points more. The loan-to-value ratio sits at 55 percent, per TASE filings. Investors included Phoenix Insurance and Meitav.
The spread tells the story. In 2022, Israeli investors accepted 4.5 percent for U.S. real estate exposure. Today, they demand 6.2 percent. That is not a market malfunction. It is a repricing of risk after a cycle of defaults.
A decade ago, U.S. developers flocked to Tel Aviv for cheaper corporate-level debt. Yoel Goldman's All Year Holdings raised hundreds of millions from Israeli pension funds and insurers. Starwood did the same. Both ended in high-profile defaults. Israeli investors learned that U.S. real estate carries execution risk, not just asset risk.
Rosen's deal suggests the spigot is open again, but selectively. The 55 percent LTV is conservative by pre-2020 standards. The 6.2 percent coupon reflects a market that demands a premium for cross-border, single-asset exposure. The investors are not retail; they are Phoenix and Meitav, sophisticated allocators who can underwrite sponsor track records.
Rosen's track record matters. He is the former brother-in-law and business partner of Alex Sapir, who owns a massive development site one block from Rosen's Miami parcel. Sapir recently relisted that site for up to $50 million. The family connection is not incidental; it signals deep local knowledge and capital relationships.
The Miami site gives Rosen time. The bond proceeds extend the runway for a 1.9 million-square-foot mixed-use project in a neighborhood that has seen significant institutional investment. The Hotel Indigo provides cash flow. The structure is a classic bridge: use stabilized cash flow to carry development risk.
The broader pattern is clear. Israeli bond market access for U.S. real estate is not dead. It is narrower, more expensive, and more discerning. PBC, owned by an Israeli parent, tapped the same market to refinance 10 Bryant Park in 2024. Sade Real Estate secured financing this month for a Houston apartment complex. The market is open for sponsors with Israeli ties, institutional-grade assets, and conservative leverage.
Rosen's $135 million raise is a data point, not a trend. But it is a telling one. Israeli investors are willing to re-engage with U.S. real estate—at a price. The 6.2 percent coupon is the new floor for cross-border, non-recourse corporate debt. The 55 percent LTV is the new ceiling. The question for every sponsor without an Israeli parent or partner: what is your cost of capital, and who is willing to provide it?